Trauma News and Research

RSS

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

GETINGE to acquire Atrium Medical

Atrium Medical Corporation, announced today that it has signed a definitive agreement to be acquired by GETINGE GROUP of Sweden and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technologies for $680 million.

3 Oct 2011

Public health officials should determine community storage of anthrax-preventing antibiotics

As part of preparations for a possible large-scale anthrax attack, public health officials on the state and local levels should determine where and how anthrax-preventing antibiotics should be stored in their communities, says a new report from the Institute of Medicine.

1 Oct 2011

Wireless Vital Signs Monitor for trauma victims enters clinical trial phase

A collaboration among a medical device innovator, the U.S. Army Institute of Surgical Research (ISR), the nonprofit National Trauma Institute and the State of Texas enters its final phase as the FDA-approved Wireless Vital Signs Monitor (WVSM) begins clinical trials this month in the Memorial Hermann Medical Center emergency department and on Houston Life Flight.

1 Oct 2011

Researchers identify protein-based blood biomarkers in patients treated with EPO

Biomarkers in the bloodstream could provide a rapid assessment of therapeutic intervention in ischemic stroke and allow patient stratification

1 Oct 2011

Nutrition experts participated in PN Safety Summit to discuss safety of PN therapy, patient care

Recent safety concerns in the preparation and delivery of parenteral nutrition, commonly referred to as intravenous nutrition, prompted leaders from several major organizations to participate in a PN Safety Summit on September 23, 2011.

From Baxter International Inc. 1 Oct 2011

Baxter seeks European marketing authorization for HyQ to treat PI

Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.

From Baxter International Inc. 1 Oct 2011

Journal of Vascular Surgery publishes Atrium's COBEST Trial on aorto-iliac disease

Atrium Medical Corporation today announced the publication of the COBEST Trial by the Journal of Vascular Surgery. COBEST (Covered Versus Balloon Expandable Stent Trial) was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that has demonstrated that Atrium's proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

30 Sep 2011

MRI-based technique allows researchers to follow neural stem cells in vivo

Carnegie Mellon University biologists have developed an MRI-based technique that allows researchers to non-invasively follow neural stem cells in vivo.

30 Sep 2011

X-chromosome related microRNA may impact immunity and cancer

As anyone familiar with the phrase 'man-flu' will know women consider themselves to be the more robust side of the species when it comes to health and illness. Now new research, published in BioEssays, seems to support the idea. The research focuses on the role of MicroRNAs encoded on the X chromosome to explain why women have stronger immune systems to men and are less likely to develop cancer.

28 Sep 2011

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

The authors write: "We find that out-of-pocket medical spending is approximately 29 percent higher when an individual becomes widowed, a large portion of which is spending on nursing homes. Our results suggest a substantial role of living arrangements in out-of-pocket medical spending; however, our estimates combined with differences in rates of widowhood across gender suggest that marital status can explain only one third of the gender difference in total out-of-pocket medical spending, leaving a large portion unexplained.

27 Sep 2011

Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy

Cannabidiol—a compound derived from marijuana—may be a promising new treatment to prevent the development of painful neuropathy in patients receiving the chemotherapy drug paclitaxel, according to animal experiments reported in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

26 Sep 2011

Study: Torontonians want non-profit organizations to provide programs and services

Torontonians want non-profit organizations to provide programs and services in their neighbourhoods that are relevant to their needs, held at convenient times and locations and have stable funding, a research study has found.

23 Sep 2011

Tips for parents to keep their kids safe while traveling in the car

In honor of National Child Passenger Safety Week Loyola University Health System safety expert offers tips on keeping children safe in the car. Car accidents remain the leading cause of death and disability in children in the United States. Stricter laws and car seat education programs have dramatically decreased the mortality and morbidity rates in motor vehicle accidents in the last several years. Yet, thousands of children die or are injured in car accidents each year.

23 Sep 2011

Verax Biomedical receives FDA clearance for Platelet PGD test

A $30 test that takes fewer than 30 minutes to perform can prevent potentially deadly transfusions of bacterial contamination in platelets, according to a new study published in the peer-reviewed journal Transfusion. An early view of the study can be found at the journal's web site.

23 Sep 2011

Jefferson experts review most commonly used CAM practices for mood disorders

Mood disorders are among the most prevalent mental health issues today. While medication is available, more and more people are turning to complementary and alternative medicine (CAM), including herbal remedies, acupuncture, and meditation to help manage their mood disorders.

22 Sep 2011

Children's Medical Center employees, volunteers and vendors to get free flu shots

For the first time, Children's Medical Center will require all employees, contractors, volunteers and vendors to get influenza vaccinations this fall to protect the health and safety of the hospital's patients.

22 Sep 2011

Cannabinoids may block development of PTSD symptoms after traumatic experience

Cannabinoids (marijuana) administration after experiencing a traumatic event blocks the development of post-traumatic stress disorder (PTSD)-like symptoms in rats, according to a new study conducted at the University of Haifa and published in the journal Neuropsychopharmacology.

22 Sep 2011

Ariel Pharmaceuticals in-licenses AP-1531 from BTG for acute migraine attacks

Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd.

22 Sep 2011

Smith & Nephew's TRUCLEAR System to improve training for gynecologists

Smith & Nephew plc, the global medical technology business, today announced the introduction of its TRUCLEAR SIM Morcellation Simulator, a highly-realistic, hands-on simulator designed to improve training for gynecologists who perform hysteroscopic morcellation, a procedure to remove intrauterine polyps and fibroids.

21 Sep 2011

Trauma News and Research

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

GETINGE to acquire Atrium Medical

Public health officials should determine community storage of anthrax-preventing antibiotics

Wireless Vital Signs Monitor for trauma victims enters clinical trial phase

Researchers identify protein-based blood biomarkers in patients treated with EPO

Nutrition experts participated in PN Safety Summit to discuss safety of PN therapy, patient care

Baxter seeks European marketing authorization for HyQ to treat PI

Journal of Vascular Surgery publishes Atrium's COBEST Trial on aorto-iliac disease

MRI-based technique allows researchers to follow neural stem cells in vivo

X-chromosome related microRNA may impact immunity and cancer

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy

Study: Torontonians want non-profit organizations to provide programs and services

Tips for parents to keep their kids safe while traveling in the car

Verax Biomedical receives FDA clearance for Platelet PGD test

Jefferson experts review most commonly used CAM practices for mood disorders

Children's Medical Center employees, volunteers and vendors to get free flu shots

Cannabinoids may block development of PTSD symptoms after traumatic experience

Ariel Pharmaceuticals in-licenses AP-1531 from BTG for acute migraine attacks

Smith & Nephew's TRUCLEAR System to improve training for gynecologists

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News